The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Scientists Call for a National Microbiome “Moonshot” to Tackle Chronic Disease• The Oral Delivery Challenge: Why It Requires More Than the Right Route• Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats•
Capsugel Lonza — A Better Way to Deliver Microbiome-Based Therapies

Latest in the News

All News →
Scientists Call for a National Microbiome “Moonshot” to Tackle Chronic Disease
 REGULATORY & POLICY

Scientists Call for a National Microbiome “Moonshot” to Tackle Chronic Disease

An international commentary led by Rutgers’ Martin Blaser sets ten priorities for coordinated microbiome research and education, with emphasis on pregnancy and early childhood.

BY Andrew Smith · OCT 30, 2026 · 4 MIN READ
The Oral Delivery Challenge: Why It Requires More Than the Right Route
CLINICAL & MANUFACTURING

The Oral Delivery Challenge: Why It Requires More Than the Right Route

OCT 26, 2026
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets
BIOTICS AND SUPPLEMENTS

Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets

OCT 22, 2026
Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development
CLINICAL & MANUFACTURING

Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development

OCT 16, 2026
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment
EDITOR'S CHOICE

Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment

SEP 28, 2026
Claude Discovers Novel Enzyme System with CRISPR-like Repeats
GMO & SYNBIO

Claude Discovers Novel Enzyme System with CRISPR-like Repeats

SEP 25, 2026
Evonik EUDRACAP colon - GMP quality targeted drug delivery from the upper small intestine to the ileo-colonic region

Editor's Choice

All Editor's Choice →
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment
 Editor's Choice

Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment

Prokarium’s live bacterial immunotherapy ZH9 aims to redefine the non-muscle invasive bladder cancer treatment paradigm, building upon the precedence of BCG with a product designed for real-world urology practice.

BY Nick Glanville, Livija Deban and Dara Henry · SEP 28, 2026 · 9 MIN READ
A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation
Editor's Choice

A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation

SEP 1, 2026
Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?
Editor's Choice

Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?

AUG 10, 2026